Clinical trial
A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in…
NCT00001570 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001570 |
|---|---|
| Title | A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer |
| Official title | A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Neoplasms, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | PSC 833, vinblastine |
| Enrollment | 46 |
| Start date | Feb 1, 1997 |
| Completion | Jan 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: